Information for you
On this page, you will find information on the Agency’s activities that are most relevant to healthcare professionals, including news, and events.
You can contribute to the Agency’s work by responding to public consultations.
Learn more about how Healthcare Professionals are actively involved in the work of the Agency.
Workshop on social media
EMA’s Patients’ and Consumers’ Organisations Working Party and Healthcare Professionals’ Organisations Working Party discussed challenges and practical applications of social media and their impact on regulators, patients and healthcare professionals during a workshop held on 19 September 2016. EMA will publish the presentations and a meeting report on the event page.
It was the first in a series of meetings relating to advances in digital health, including social media, ‘big data’ analysis and Innovative Medicines Initiative projects such as WEB-RADR, where EMA will provide a platform for discussion and mutual learning.
Tenth stakeholder forum on pharmacovigilance legislation
This forum brought together regulators with patients, healthcare professionals and industry, to take stock of what has been achieved and what needs to be the focus over the coming years. EMA has published the presentations on the event page.
Healthcare Professionals’ Working Party elects co-chair
EMA's Healthcare Professionals' Working Party re-elected Gonzalo Calvo as its co-chair at the September 2016 meeting. Professor Calvo, a physician by education and consultant in clinical pharmacology in Barcelona, Spain, has extensive experience in medicines regulation, including nearly ten years as a member of the Committee for Medicinal Products for Human Use.
Annual report on EMA patient and healthcare professional interactions
EMA has published its 2015 annual report on its interactions with patients, consumers, healthcare professionals and their organisations.The report demonstrates the Agency’s continued commitment to incorporating these stakeholders' views into the regulatory aspect of medicines development.
News for healthcare professionals
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2016
PRAC starts a safety referral and concludes one ... Read more
Review of liver cancer risk not conclusive and further studies are needed ... Read more
Workshop on adaptive pathways – discussion on development approach for medicines addressing unmet medical needs
Event to be broadcast live on 8 December ... Read more
Co-chair elected for a three-year mandate ... Read more
EMA conducts analysis of applications submitted between 1995 and 2014 ... Read more
- See all News for healthcare professionals
Events of interest
EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting: Workshop on social media
This joint PCWP/HCPWP workshop on social media is being held to discuss the challenges and practical applications of social media and their impact on regulators, healthcare professionals and patients. The objectives are to provide an overview of what social media are and what they are being used for in the context of medicines regulation; share healthcare professionals’, patients’ and regulators’ practices on how social media is used to amplify communication on medicines information and regulatory outputs; discuss how social media is being used for gathering medicine-related data; reflect on how communication and data gathering through social media may influence behaviours and attitudes towards medicines information and medicines use, impact regulatory decisions, and shape interactions with stakeholders; and to identify areas requiring action from regulators, patients and healthcare professionals. ... Read more
01/12/2016 - 02/12/2016
This key end of year conference jointly organised by TOPRA and EMA will provide an annual review of the activities of the European Medicines Agency (EMA) and the national agencies within the European regulatory system, providing European regulatory professionals a chance to reflect and plan for the challenges ahead. The conference will discuss major areas of medicines legislation coordinated by the EMA and provide practical advice on the work of EMA within the European regulatory network and on how national agencies contribute. It will feature a range of speakers and panellists from EMA and national agencies, industry, patient and healthcare professional organisation representatives and policy-makers. ... Read more
This one-day training session for representatives of patients' and consumers' organisations aims at presenting an overview of medicines evaluation with specific emphasis on where and how they can be involved. Using a hands-on interactive approach, participants will learn more about how they can contribute to scientific advice procedures, Scientific Advisory Group (SAG) meetings and in review of information for patients. ... Read more
EMA Human Scientific Committees’ Working Party with Patients’ and Consumers’ Organisations (PCWP) meeting with all eligible organisations
This final meeting for 2016 brings together members of the Patients' and Consumers' Organisations' Working Party (PCWP) and all eligible patient and consumer organisations. Discussions will include the next steps for public engagement looking towards 2020; public hearings; PCWP topic group updates; and patient interaction with consumers. EU-wide initiatives to be discussed are the HTA co-operation and ADR website enhancements. Feedback will also be given from the scientific committees. As part of the ongoing PCWP 10th anniversary celebrations, there will also be a lunch talk on ‘What do you see as the future for the voice of patients at EMA?’ The recording of this will be available at a later date. ... Read more
05/12/2016 - 06/12/2016
In January 2016 the Pharmacovigilance Risk Assessment Committee (PRAC) adopted a strategy for measuring the impact of pharmacovigilance activities performed at European Union (EU) and Member States level which relies on a collaborative approach of all stakeholders. Measuring the impact of key pharmacovigilance activities will allow regulators and stakeholders to determine which activities are most successful and to identify enablers and barriers for generating positive health impacts which will contribute to the further development of proactive pharmacovigilance systems and to promote best practice across the EU. The aim of this workshop is to facilitate the implementation of the PRAC strategy with a particular focus on the development of methodologies and the fostering of collaboration. ... Read more
- See all Events of interest